Consensus MedinCell S.A.

Equities

MEDCL

FR0004065605

Market Closed - Euronext Paris Other stock markets 11:37:12 2024-04-26 am EDT			5-day change	1st Jan Change
12.66 ^EUR	+2.10%		+14.05%	+75.83%

Apr. 17	Medincell: share price rises following agreement with AbbVie	CF
Apr. 16	Medincell, AbbVie to Co-Develop Injectable Therapeutics	DJ

Evolution of the average Target Price on MedinCell S.A.

Price target over the last 5 years

History of analyst recommendation changes

eb9028a91728d6317b54069aa9cade.PQYO02GZbVdmdQtw__y1vbXx2Xa0dqGipxgS855rEFM.DTNahlfrKCE_R2EfzMTt79GnswbePMTF7Coqh_BcJCRvYEuDJagXAQwMZA~231b725a656c83c475ba26a336e8cec4

Analyst Recommendations on MedinCell S.A.

MedinCell: share price surges, broker in support	23-03-21	CF
MEDINCELL : Oddo raises its target price on the stock	23-03-21	CF

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

12.66 EUR

Average target price

17.15 EUR

Spread / Average Target

+35.47%

High Price Target

22 EUR

Spread / Highest target

+73.78%

Low Price Target

14 EUR

Spread / Lowest Target

+10.58%

Consensus detail

Consensus revision (last 18 months)

Ratings for MedinCell S.A.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar